Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 19

Showing 19 citing articles:

Experimental Models of COVID-19
Luis A. Caldera-Crespo, Michael J. Paidas, Sabita Roy, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 40
Safety and Efficacy of the Common Vaccines against COVID-19
Ying Liu, Qing Ye
Vaccines (2022) Vol. 10, Iss. 4, pp. 513-513
Open Access | Times Cited: 33
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Merits and challenges of iPSC-derived organoids for clinical applications
Ziran Xu, Jiaxu Yang, Xianyi Xin, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 13
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines
Thomas E. Hickey, Troy J. Kemp, Jimmie Bullock, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 10
Nucleic Acid Vaccines against SARS-CoV-2
Ying Liu, Qing Ye
Vaccines (2022) Vol. 10, Iss. 11, pp. 1849-1849
Open Access | Times Cited: 16
Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
Zahra Karami, Sharif Moradi, Akram Eidi, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 9
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro
Luiz Saramago, Marcos V. Santana, Bárbara Figueira Gomes, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 9, pp. 2866-2880
Closed Access | Times Cited: 9
Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures
Winston Chiu, Lore Verschueren, Christel Van den Eynde, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3101-3111
Open Access | Times Cited: 15
How effective are face coverings in reducing transmission of COVID-19?
Joshua F. Robinson, Ioatzin Rıos de Anda, Fergus J. Moore, et al.
Aerosol Science and Technology (2022) Vol. 56, Iss. 6, pp. 473-487
Open Access | Times Cited: 10
Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines
Guilherme Wildner, Amanda Resende Tucci, Alessandro de Souza Prestes, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1222-1222
Open Access | Times Cited: 5
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection
Flavio De Maio, Mariagrazia Rullo, Modesto de Candia, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1730-1730
Open Access | Times Cited: 4
The fast-track development of COVID-19 vaccines
Yousra A. El‐Maradny, Asmaa Ramadan, Vivek P. Chavda, et al.
Elsevier eBooks (2024), pp. 415-440
Closed Access
Understanding the molecular basis of pathogenesis of SARS-CoV-2
Mubaida Parveen, Mohammad “Sufian” Badar, Yaqoot Taban Khan, et al.
Elsevier eBooks (2024), pp. 3-49
Closed Access
Host Genetic Diversity of SARS-CoV
Firasat Hussain, Hamid Ali, Ateeqah Siddique, et al.
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 87-120
Closed Access
The Potential of <i>Clerodendrum paniculatum</i> Leaves Fraction as a 3-Chymotrypsin-Like (3CL) Protease Inhibitor of SARS-CoV-2
Muhammad Arba, Arfan Arfan, Yamin Yamin, et al.
Indonesian Journal of Chemistry (2023) Vol. 23, Iss. 3, pp. 770-770
Open Access | Times Cited: 1
Radiation Recall Pneumonitis COVID-19 Infection Induced After Adjuvant Breast Cancer Radiotherapy. A Known Phenomenon in an Unknown Pandemic Disease: A Case Report
Grazia Lazzari, Renato Giua, Elisabetta Verdolino, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 2299-2304
Open Access | Times Cited: 2
Plasma gp96 is a Novel Predictive Biomarker for Severe COVID-19
Rongguo Wei, Biyan Zhou, Shaohua Li, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 2
An Automated Strategy to Handle Antigenic Variability in Immunisation Protocols, Part II: In Vitro Transcribed mRNA Vector Design for Inoculation Against Infectious Agent Variants
Glaucia C. Pereira
Methods in molecular biology (2022), pp. 323-340
Closed Access | Times Cited: 1
Page 1

Scroll to top